NCT04293432View on ClinicalTrials.gov

A Pharmacovigilance Study of Torsade de Pointes

CompletedOBSERVATIONAL
Enrollment

6,670

Participants

Timeline

Start Date

May 15, 2019

Primary Completion Date

December 22, 2019

Study Completion Date

January 1, 2020

Conditions
Torsades de Pointe Caused by Drug
Interventions
DRUG

Drugs, Generic

All drugs having ≥10 TdP cases reported in the FAERS database

Trial Locations (1)

25000

Department of Pharmacy, University of Peshawar, Peshawar

All Listed Sponsors
lead

University of Peshawar

OTHER

NCT04293432 - A Pharmacovigilance Study of Torsade de Pointes | Biotech Hunter | Biotech Hunter